Xiao-Lei Yuan
Overview
Explore the profile of Xiao-Lei Yuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang J, Yuan X, Jiang J, Zhang P, Kuang-Tan , Tan K
Exp Neurol
. 2025 Jan;
386:115167.
PMID: 39884329
Parkinson's disease is the second most common neurodegenerative disease, characterized by substantial loss of dopaminergic (DA) neurons, the formation of Lewy bodies (LBs) in the substantia nigra, and pronounced neuroinflammation....
2.
Gu S, Xie Z, Gu M, Wang C, Xu L, Gao C, et al.
Sci Rep
. 2024 Jul;
14(1):15107.
PMID: 38956066
Ferroptosis is an iron-dependent cell death form characterized by reactive oxygen species (ROS) overgeneration and lipid peroxidation. Myricetin, a flavonoid that exists in numerous plants, exhibits potent antioxidant capacity. Given...
3.
Gu S, Yuan X, Yin P, Li Y, Wang C, Gu M, et al.
Front Neurol
. 2024 Jun;
15:1388131.
PMID: 38846031
Background: The association between body mass index (BMI) and rapid eye-movement (REM) sleep-related behavioral disorder (RBD) in Parkinson's disease (PD) remains unknown. Our study was to investigate the association of...
4.
Gu S, Shi R, Gao C, Yuan X, Wu Y, Liu Z, et al.
Sci Rep
. 2023 Sep;
13(1):14548.
PMID: 37666916
Autonomic symptoms (AS) are critical in Parkinson's disease (PD). We aimed to determine the relative significance of clinical factors allowing predictions about incidence of AS, and examine AS profiles among...
5.
Gu S, Shi R, Gaoag C, Yuan X, Wu Y, Zhang Y, et al.
Phytomedicine
. 2022 Oct;
108:154497.
PMID: 36283254
Background: Pingchan granule (PCG) is a traditional Chinese medicine for Parkinson's disease (PD). Hypothesis/purpose: This was the first study aiming to evaluate the efficacy and safety of PCG for motor...
6.
Ye Q, Yuan X, Yuan C, Zhang H, Yang X
Neural Regen Res
. 2018 Jul;
13(7):1269-1275.
PMID: 30028337
Levodopa preparations remain the preferred drug for Parkinson's disease. However, long-term use of levodopa may lead to a series of motor complications. Previous studies have shown that the combination of...
7.
Ye Q, Yuan X, He J, Zhou J, Yuan C, Yang X
Neural Regen Res
. 2016 Dec;
11(10):1625-1632.
PMID: 27904494
Levodopa is the gold-standard treatment for Parkinson's disease. However, although it alleviates the clinical symptoms, it cannot delay the progressive apoptosis of dopaminergic neurons or prevent motor complications in the...
8.
Ye Q, Yuan X, Zhou J, Yuan C, Yang X
Evid Based Complement Alternat Med
. 2014 Dec;
2014:342506.
PMID: 25477990
This study was performed to observe the effects of Zishenpingchan granule on neurobehavioral manifestations and the activity and gene expression of striatal dopamine D1 and D2 receptors of rats with...